PAA 0.00% 19.5¢ pharmaust limited

PharmAust MPL - Effectiveness against Cancer and COVID-19.

  1. 2,335 Posts.
    lightbulb Created with Sketch. 274
    For those not familiar with PharmAust Monepantel (MPL) drug, here is a 6 min clip on and its effectiveness against mTOR pathway in fighting cancer and now COVID-19 (95% reduction in vitro). Not long now for some phase 1 trial results:

    PharmAust MPL

    Here is some further background information:

    Mpl and human trials
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.